• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于通过在性交期间加速替诺福韦的阴道释放来预防艾滋病毒性传播的智能冻干双凝胶剂

Smart Freeze-Dried Bigels for the Prevention of the Sexual Transmission of HIV by Accelerating the Vaginal Release of Tenofovir during Intercourse.

作者信息

Martín-Illana Araceli, Notario-Pérez Fernando, Cazorla-Luna Raúl, Ruiz-Caro Roberto, Veiga María Dolores

机构信息

Departamento de Farmacia Galénica y Tecnología Alimentaria, Facultad de Farmacia, Universidad Complutense de Madrid, 28040-Madrid, Spain.

出版信息

Pharmaceutics. 2019 May 13;11(5):232. doi: 10.3390/pharmaceutics11050232.

DOI:10.3390/pharmaceutics11050232
PMID:31086015
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6571877/
Abstract

Sub-Saharan African women are still at risk from the human immunodeficiency virus (HIV), and sex with men is the main route of transmission. Vaginal formulations containing antiretroviral drugs are promising tools to give women the power to protect themselves. The aim of this work was to obtain freeze-dried bigels containing pectin, chitosan, or hypromellose for the vaginal controlled release of Tenofovir, which is accelerated in the presence of semen. Nine batches of bigels were formulated using different proportions of these polymers in the hydrogel (1, 2, and 3% /). The bigels obtained were freeze-dried and then underwent hardness and deformability, mucoadhesion, swelling, and drug release tests, the last two in simulated vaginal fluid (SVF) and SVF/simulated seminal fluid (SSF) mixture. The formulation containing 3% pectin (fd3P) has the highest values for hardness, resistance to deformation, and good mucoadhesivity. Its swelling is conditioned by the pH of the medium, which is responsive to the controlled release of Tenofovir in SVF, with the fastest release in the SVF/SSF mixture. fd3P would be an interesting smart microbicidal system to allow faster release of Tenofovir in the presence of semen, and thus increase women's ability to protect themselves from the sexual transmission of HIV.

摘要

撒哈拉以南非洲地区的女性仍面临感染人类免疫缺陷病毒(HIV)的风险,与男性发生性行为是主要传播途径。含有抗逆转录病毒药物的阴道制剂是赋予女性自我保护能力的有前景的工具。这项工作的目的是制备含有果胶、壳聚糖或羟丙甲纤维素的冻干双凝胶,用于替诺福韦的阴道控释,替诺福韦在精液存在时释放加速。使用水凝胶中这些聚合物的不同比例(1%、2%和3%)配制了九批双凝胶。将得到的双凝胶冻干,然后进行硬度和变形性、粘膜粘附性、溶胀性和药物释放测试,后两项测试在模拟阴道液(SVF)和SVF/模拟精液(SSF)混合物中进行。含有3%果胶的制剂(fd3P)在硬度、抗变形性和良好的粘膜粘附性方面具有最高值。其溶胀受介质pH值的影响,这对替诺福韦在SVF中的控释有响应,在SVF/SSF混合物中释放最快。fd3P将是一个有趣的智能杀菌系统,可在精液存在时使替诺福韦更快释放,从而增强女性预防HIV性传播的自我保护能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3273/6571877/df4c90c5ca2c/pharmaceutics-11-00232-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3273/6571877/43c6d73f25b0/pharmaceutics-11-00232-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3273/6571877/22ca4df2b2ce/pharmaceutics-11-00232-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3273/6571877/c35836d4634e/pharmaceutics-11-00232-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3273/6571877/8abf725b8d37/pharmaceutics-11-00232-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3273/6571877/c4c062ab5346/pharmaceutics-11-00232-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3273/6571877/df4c90c5ca2c/pharmaceutics-11-00232-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3273/6571877/43c6d73f25b0/pharmaceutics-11-00232-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3273/6571877/22ca4df2b2ce/pharmaceutics-11-00232-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3273/6571877/c35836d4634e/pharmaceutics-11-00232-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3273/6571877/8abf725b8d37/pharmaceutics-11-00232-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3273/6571877/c4c062ab5346/pharmaceutics-11-00232-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3273/6571877/df4c90c5ca2c/pharmaceutics-11-00232-g006.jpg

相似文献

1
Smart Freeze-Dried Bigels for the Prevention of the Sexual Transmission of HIV by Accelerating the Vaginal Release of Tenofovir during Intercourse.用于通过在性交期间加速替诺福韦的阴道释放来预防艾滋病毒性传播的智能冻干双凝胶剂
Pharmaceutics. 2019 May 13;11(5):232. doi: 10.3390/pharmaceutics11050232.
2
Chitosan-Based Mucoadhesive Vaginal Tablets for Controlled Release of the Anti-HIV Drug Tenofovir.用于抗艾滋病毒药物替诺福韦控释的壳聚糖基粘膜粘附阴道片。
Pharmaceutics. 2019 Jan 5;11(1):20. doi: 10.3390/pharmaceutics11010020.
3
Freeze-dried bioadhesive vaginal bigels for controlled release of Tenofovir.冻干型生物黏附性阴道制剂,用于控制替诺福韦的释放。
Eur J Pharm Sci. 2019 Jan 15;127:38-51. doi: 10.1016/j.ejps.2018.10.013. Epub 2018 Oct 19.
4
Smart vaginal bilayer films of Tenofovir based on Eudragit® L100/natural polymer for the prevention of the sexual transmission of HIV.基于 Eudragit® L100/天然聚合物的替诺福韦智能阴道双层膜,用于预防艾滋病毒的性传播。
Int J Pharm. 2021 Jun 1;602:120665. doi: 10.1016/j.ijpharm.2021.120665. Epub 2021 Apr 30.
5
Vaginal Polyelectrolyte Layer-by-Layer Films Based on Chitosan Derivatives and Eudragit S100 for pH Responsive Release of Tenofovir.基于壳聚糖衍生物和 Eudragit S100 的阴道聚电解质层层薄膜,用于 pH 响应性释放替诺福韦。
Mar Drugs. 2020 Jan 9;18(1):44. doi: 10.3390/md18010044.
6
Optimization of tenofovir release from mucoadhesive vaginal tablets by polymer combination to prevent sexual transmission of HIV.通过聚合物组合优化从黏膜粘附阴道片中释放替诺福韦以预防 HIV 的性传播。
Carbohydr Polym. 2018 Jan 1;179:305-316. doi: 10.1016/j.carbpol.2017.10.001. Epub 2017 Oct 3.
7
Influence of Chitosan Swelling Behaviour on Controlled Release of Tenofovir from Mucoadhesive Vaginal Systems for Prevention of Sexual Transmission of HIV.壳聚糖溶胀行为对替诺福韦从用于预防HIV性传播的粘膜粘附阴道给药系统中控制释放的影响。
Mar Drugs. 2017 Feb 21;15(2):50. doi: 10.3390/md15020050.
8
Improvement of Tenofovir vaginal release from hydrophilic matrices through drug granulation with hydrophobic polymers.通过疏水聚合物药物造粒改善亲水基质中替诺福韦的阴道释放。
Eur J Pharm Sci. 2018 May 30;117:204-215. doi: 10.1016/j.ejps.2018.02.022. Epub 2018 Mar 21.
9
Mucoadhesive Vaginal Discs based on Cyclodextrin and Surfactants for the Controlled Release of Antiretroviral Drugs to Prevent the Sexual Transmission of HIV.基于环糊精和表面活性剂的粘膜粘附阴道片用于抗逆转录病毒药物的控释以预防性传播HIV
Pharmaceutics. 2020 Apr 2;12(4):321. doi: 10.3390/pharmaceutics12040321.
10
Development of pH-sensitive vaginal films based on methacrylate copolymers for topical HIV-1 pre-exposure prophylaxis.基于甲基丙烯酸酯共聚物的pH敏感型阴道薄膜用于局部HIV-1暴露前预防的研发。
Acta Biomater. 2021 Feb;121:316-327. doi: 10.1016/j.actbio.2020.12.019. Epub 2020 Dec 14.

引用本文的文献

1
Physicochemical Properties of Freeze-Dried Bigel-Based Materials Composed of Sodium Alginate/Whey Protein Isolate Hydrogel and Ethylcellulose/Sunflower Oil Oleogel.由海藻酸钠/乳清蛋白分离物水凝胶和乙基纤维素/葵花籽油油凝胶组成的冻干双凝胶基材料的物理化学性质
Biomacromolecules. 2025 Apr 14;26(4):2344-2355. doi: 10.1021/acs.biomac.4c01677. Epub 2025 Mar 25.
2
Novel nutraceutical delivery system utilizing a bigel formulated with sesame oil, kokum butter, and pectin.利用由芝麻油、印度芒果脂和果胶配制而成的双凝胶的新型营养保健品递送系统。
Food Sci Biotechnol. 2024 May 13;33(13):3067-3082. doi: 10.1007/s10068-024-01559-3. eCollection 2024 Oct.
3

本文引用的文献

1
Dapivirine Bioadhesive Vaginal Tablets Based on Natural Polymers for the Prevention of Sexual Transmission of HIV.基于天然聚合物的达匹韦林生物黏附阴道片用于预防HIV性传播
Polymers (Basel). 2019 Mar 13;11(3):483. doi: 10.3390/polym11030483.
2
Key characteristics and modelling of bigels systems: A review.大凝胶系统的关键特性与建模:综述。
Mater Sci Eng C Mater Biol Appl. 2019 Apr;97:932-953. doi: 10.1016/j.msec.2018.12.075. Epub 2018 Dec 26.
3
Chitosan-Based Mucoadhesive Vaginal Tablets for Controlled Release of the Anti-HIV Drug Tenofovir.
Hydrogel- and Nanocomposite-Based Drug-Delivery Strategies in the Treatment of Vaginal Infections.
基于水凝胶和纳米复合材料的药物递送策略在阴道感染治疗中的应用
Polymers (Basel). 2024 Mar 12;16(6):775. doi: 10.3390/polym16060775.
4
Development and Evaluation of Two-Phase Gel Formulations for Enhanced Delivery of Active Ingredients: Sodium Diclofenac and Camphor.用于增强活性成分递送的两相凝胶制剂的开发与评价:双氯芬酸钠和樟脑
Pharmaceutics. 2024 Mar 5;16(3):366. doi: 10.3390/pharmaceutics16030366.
5
Bigels as Delivery Systems: Potential Uses and Applicability in Food.水凝胶作为递送系统:在食品中的潜在用途及适用性
Gels. 2023 Aug 11;9(8):648. doi: 10.3390/gels9080648.
6
Recent Advances in Pharmaceutical Approaches of Antimicrobial Agents for Selective Delivery in Various Administration Routes.抗菌药物在不同给药途径中实现选择性递送的药学方法的最新进展
Antibiotics (Basel). 2023 Apr 27;12(5):822. doi: 10.3390/antibiotics12050822.
7
Effect of flaxseed gum on the brittleness of oleogels based on candelilla wax.亚麻籽胶对基于小烛树蜡的油凝胶脆性的影响。
RSC Adv. 2022 Oct 27;12(47):30734-30741. doi: 10.1039/d2ra04341f. eCollection 2022 Oct 24.
8
Enzyme Responsive Vaginal Microbicide Gels Containing Maraviroc and Tenofovir Microspheres Designed for Acid Phosphatase-Triggered Release for Pre-Exposure Prophylaxis of HIV-1: A Comparative Analysis of a Bigel and Thermosensitive Gel.含马拉维若和替诺福韦微球的酶响应性阴道杀微生物剂凝胶,设计用于酸性磷酸酶触发释放以进行HIV-1暴露前预防:双凝胶和热敏凝胶的比较分析
Gels. 2021 Dec 24;8(1):15. doi: 10.3390/gels8010015.
9
Naturally Occurring Polyelectrolytes and Their Use for the Development of Complex-Based Mucoadhesive Drug Delivery Systems: An Overview.天然存在的聚电解质及其在基于复合物的黏膜黏附药物递送系统开发中的应用:综述
Polymers (Basel). 2021 Jul 8;13(14):2241. doi: 10.3390/polym13142241.
10
Promising Drug Delivery Approaches to Treat Microbial Infections in the Vagina: A Recent Update.治疗阴道微生物感染的有前景的药物递送方法:最新进展
Polymers (Basel). 2020 Dec 23;13(1):26. doi: 10.3390/polym13010026.
用于抗艾滋病毒药物替诺福韦控释的壳聚糖基粘膜粘附阴道片。
Pharmaceutics. 2019 Jan 5;11(1):20. doi: 10.3390/pharmaceutics11010020.
4
Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial.替诺福韦 1%阴道凝胶预防南非妇女感染 HIV-1(FACTS-001):一项 3 期、随机、双盲、安慰剂对照试验。
Lancet Infect Dis. 2018 Nov;18(11):1241-1250. doi: 10.1016/S1473-3099(18)30428-6. Epub 2018 Oct 24.
5
Freeze-dried bioadhesive vaginal bigels for controlled release of Tenofovir.冻干型生物黏附性阴道制剂,用于控制替诺福韦的释放。
Eur J Pharm Sci. 2019 Jan 15;127:38-51. doi: 10.1016/j.ejps.2018.10.013. Epub 2018 Oct 19.
6
Role of chitosan on controlling the characteristics and antifungal activity of bioadhesive fluconazole vaginal tablets.壳聚糖在控制生物黏附性氟康唑阴道片特性及抗真菌活性方面的作用
Saudi Pharm J. 2018 Feb;26(2):151-161. doi: 10.1016/j.jsps.2017.12.016. Epub 2017 Dec 23.
7
FAME-04: A Phase 1 trial to assess the safety, acceptability, pharmacokinetics and pharmacodynamics of film and gel formulations of tenofovir.FAME-04 研究:评估替诺福韦薄膜和凝胶制剂的安全性、可接受性、药代动力学和药效学的 1 期临床试验。
J Int AIDS Soc. 2018 Aug;21(8):e25156. doi: 10.1002/jia2.25156.
8
Pharmacology of Antiretrovirals in the Female Genital Tract for HIV Prevention.抗逆转录病毒药物在女性生殖道预防 HIV 感染中的药理学。
J Clin Pharmacol. 2018 Nov;58(11):1381-1395. doi: 10.1002/jcph.1270. Epub 2018 Jun 14.
9
Effects of gel volume on pharmacokinetics for vaginal and rectal applications of combination DuoGel-IQB4012, a dual chamber-dual drug HIV microbicide gel, in pigtailed macaques.凝胶体积对 DuoGel-IQB4012(一种双室双药 HIV 杀微生物剂凝胶)阴道和直肠应用于长尾猕猴的药代动力学的影响。
Drug Deliv Transl Res. 2018 Oct;8(5):1180-1190. doi: 10.1007/s13346-018-0538-0.
10
Improvement of Tenofovir vaginal release from hydrophilic matrices through drug granulation with hydrophobic polymers.通过疏水聚合物药物造粒改善亲水基质中替诺福韦的阴道释放。
Eur J Pharm Sci. 2018 May 30;117:204-215. doi: 10.1016/j.ejps.2018.02.022. Epub 2018 Mar 21.